1. Home
  2. PNTG vs TYRA Comparison

PNTG vs TYRA Comparison

Compare PNTG & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

HOLD

Current Price

$28.94

Market Cap

841.6M

Sector

Health Care

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$22.11

Market Cap

844.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNTG
TYRA
Founded
2019
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
841.6M
844.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PNTG
TYRA
Price
$28.94
$22.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$35.33
$31.20
AVG Volume (30 Days)
299.1K
462.3K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
10.47
N/A
EPS
0.75
N/A
Revenue
$847,274,000.00
N/A
Revenue This Year
$36.69
N/A
Revenue Next Year
$24.06
N/A
P/E Ratio
$38.32
N/A
Revenue Growth
29.89
N/A
52 Week Low
$21.18
$6.42
52 Week High
$31.57
$22.83

Technical Indicators

Market Signals
Indicator
PNTG
TYRA
Relative Strength Index (RSI) 65.94 72.42
Support Level $28.61 $20.08
Resistance Level $30.26 $22.83
Average True Range (ATR) 0.97 1.60
MACD 0.27 0.20
Stochastic Oscillator 72.59 89.04

Price Performance

Historical Comparison
PNTG
TYRA

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: